The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Valuation Is Forecasted For The Personalized Cancer Vaccines Market By 2030 Starting From Its 2026 Size?
The personalized cancer vaccines market size has demonstrated robust growth in recent years. It is anticipated to increase from $256.65 billion in 2025 to $273.05 billion in 2026, at a compound annual growth rate (CAGR) of 6.4%. This historical expansion can be attributed to advancements in cancer genomics, the unmet need in oncology treatments, the limitations of traditional cancer therapies, the surge in immunotherapy research, and heightened funding for cancer research.
The personalized cancer vaccines market is projected to experience substantial expansion over the upcoming years. By 2030, its size is anticipated to reach $350.3 billion, demonstrating a compound annual growth rate (CAGR) of 6.4%. This projected growth during the forecast period is primarily driven by factors such as the wider adoption of personalized medicine, an increase in cancer incidence rates, advancements in neoantigen discovery, growing partnerships among biotech companies, and favorable regulatory environments. Key trends anticipated in this period encompass an elevated focus on personalized immunotherapy, the expanded application of genomic tumor profiling, the development of therapeutic cancer vaccines, increased integration with precision oncology, and a surge in clinical trial activities for cancer vaccines.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19136&type=smp
What Major Growth Drivers Are Shaping The Outlook Of The Personalized Cancer Vaccines Market?
The increasing occurrence of cancer is anticipated to fuel the expansion of the personalized cancer vaccine market in the future. Cancer refers to a variety of diseases marked by unregulated cell proliferation that can infiltrate adjacent tissues and spread throughout the body. The escalating prevalence of cancer is driven by aging demographics, evolving lifestyle patterns, environmental exposures, and advancements in diagnostic methods. The personalized cancer vaccine market supports cancer care by providing vaccines tailored to patient-specific tumor antigens, thereby strengthening the immune system’s ability to detect and eradicate cancer cells. For instance, in July 2024, according to the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, cancer diagnoses in Australia rose from 160,570 cases in 2022 to 164,694 cases in 2023, indicating a significant year-over-year increase. Consequently, the rising prevalence of cancer is a key factor driving the growth of the personalized cancer vaccine market.
Which Segment Categories Define The Personalized Cancer Vaccines Market?
The personalized cancer vaccines market covered in this report is segmented –
1) By Treatment Type: Preventive Cancer Vaccines, Therapeutic Cancer Vaccines
2) By Cancer Type: Lung Cancer, Breast Cancer, Colorectal Cancer, Leukemia, Prostate Cancer, Cervical Cancer, Glioblastoma
3) By Mechanism Of Action: Tumor Associated Antigens (TAAs), Tumor Specific Antigens (TSAs), Somatic Mutations In Cancer Pharmacogenomics, Pharmacogenomics Towards Genomic Polymorphism, Other Mechanisms Of Action
4) By Route Of Administration: Injectables, Other Routes Of Administration
5) By End Use: Hospitals, Clinic, Other End Users
Subsegments:
1) By Preventive Cancer Vaccines: HPV Vaccines, Hepatitis B Vaccines, Combination Vaccines
2) By Therapeutic Cancer Vaccines: Dendritic Cell Vaccines, Peptide-Based Vaccines, DNA Vaccines, RNA Vaccines, Whole Cell Vaccines
What Major Market Trends Are Driving Changes In The Personalized Cancer Vaccines Market?
Major companies operating in the personalized cancer vaccine market are focusing on developing advanced therapeutic solutions, such as personalized immunotherapy designed to target patient-specific tumor mutations, to enhance treatment precision and improve clinical outcomes. Personalized immunotherapy refers to customized cancer treatments that use a patient’s own genetic and tumor mutation profile often delivered through dendritic cell–based vaccines or neoantigen-targeted platforms to activate a tailored immune response against malignant cells. For instance, in August 2024, UCLA Health, a US-based healthcare organization, launched a first-of-its-kind clinical trial evaluating a personalized cancer vaccine that targets the H3 G34 mutation in diffuse hemispheric gliomas, using dendritic cells to stimulate immunity against the RNA disruptions caused by this aggressive mutation, offering a promising therapeutic option for adolescents and young adults who typically have limited treatment choices and poor survival rates.
Who Are The Top Companies Competing In The Personalized Cancer Vaccines Market?
Major companies operating in the personalized cancer vaccines market are Moderna Inc., CureVac AG, BioNTech SE, Genentech Inc., Merck & Co. Inc., GlaxoSmithKline plc, Achilles Therapeutics Plc, Evaxion Biotech AS, Geneos Therapeutics Inc., ISA Pharmaceuticals BV, VAXIMM GmbH, EpiVax Therapeutics Inc., Personalis Inc., Catalent Inc., Gritstone bio Inc., Neon Therapeutics Inc., Nouscom AG, Vaccitech plc, Agenus Inc., Transgene SA
Read the full personalized cancer vaccines market report here:
https://www.thebusinessresearchcompany.com/report/personalized-cancer-vaccines-global-market-report
Which Regions Are Projected To Dominate The Personalized Cancer Vaccines Market In The Coming Years?
North America was the largest region in the personalized cancer vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cancer vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Personalized Cancer Vaccines Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=19136&type=smp
Browse Through More Reports Similar to the Global Personalized Cancer Vaccines Market 2026, By The Business Research Company
Therapeutic Bcg Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Cervical Cancer Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/cervical-cancer-vaccine-global-market-report
Dendritic Cell Cancer Vaccine Market Report 2026
https://www.thebusinessresearchcompany.com/report/dendritic-cell-cancer-vaccine-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model